Prognostic factors for recurrence and survival in anal cancer

Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy

(2012) Camilla Molich Hoff   ACTA ONCOLOGICA

Induction Chemotherapy and Dose Intensification of the Radiation Boost in Locally Advanced Anal Canal Carcinoma: Final Analysis of the Randomized UNICANCER ACCORD 03 Trial

(2012) Didier Peiffert et al.   JOURNAL OF CLINICAL ONCOLOGY

Outcomes and Prognostic Factors for Squamous-Cell Carcinoma of the Anal Canal

(2011) Karl Y. Bilimoria et al.   DISEASES OF THE COLON & RECTUM

The Prognostic Value of Hemoglobin in Patients With Anal Cancer Treated With Chemoradiotherapy

(2011) Gloria B. Roldán et al.   DISEASES OF THE COLON & RECTUM

Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer

(2011) Seiji Mabuchi et al.   GYNECOLOGIC ONCOLOGY

Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)

(2010) J Northover et al.   BRITISH JOURNAL OF CANCER

Prognostic factors derived from a prospective database dictate clinical biology of anal cancer

(2010) Jaffer A. Ajani et al.   CANCER

Systemic inflammation, nutritional status and survival in patients with cancer

(2009) Donald C McMillan   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Fluorouracil, Mitomycin, and Radiotherapy vs Fluorouracil, Cisplatin, and Radiotherapy for Carcinoma of the Anal Canal

(2008) Jaffer A. Ajani   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION